Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.

Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich SN.

Aliment Pharmacol Ther. 2003 Oct 15;18(8):767-76.

2.

Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.

Pace F, Negrini C, Wiklund I, Rossi C, Savarino V; ITALIAN ONE INVESTIGATORS STUDY GROUP.

Aliment Pharmacol Ther. 2005 Aug 15;22(4):349-56.

3.

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.

Malfertheiner P, Nocon M, Vieth M, Stolte M, Jaspersen D, Koelz HR, Labenz J, Leodolter A, Lind T, Richter K, Willich SN.

Aliment Pharmacol Ther. 2012 Jan;35(1):154-64. doi: 10.1111/j.1365-2036.2011.04901.x. Epub 2011 Nov 9.

4.

Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.

Johnson D, Crawley JA, Hwang C, Brown K.

Aliment Pharmacol Ther. 2010 Jul;32(2):182-90. doi: 10.1111/j.1365-2036.2010.04339.x. Epub 2010 Apr 29.

5.
6.

Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.

Chand N, Johnson DA, Tabangin M, Ware JC.

Aliment Pharmacol Ther. 2004 Nov 1;20(9):969-74.

7.
8.

Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.

Tolia V, Gilger MA, Barker PN, Illueca M.

J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):593-8. doi: 10.1097/MPG.0b013e3181ddcf11.

PMID:
20706150
9.

Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.

Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T.

Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:10-8.

10.

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study.

Kulig M, Nocon M, Vieth M, Leodolter A, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich SN.

J Clin Epidemiol. 2004 Jun;57(6):580-9.

PMID:
15246126
11.

Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.

Bardhan KD, Berghöfer P.

Digestion. 2007;75 Suppl 1:87-100. Epub 2007 May 4. Review.

PMID:
17489037
12.

Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.

Nocon M, Labenz J, Jaspersen D, Leodolter A, Richter K, Vieth M, Lind T, Malfertheiner P, Willich SN.

Aliment Pharmacol Ther. 2009 Mar 15;29(6):662-8. doi: 10.1111/j.1365-2036.2008.03921.x.

13.

Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment.

Giannini EG, Zentilin P, Dulbecco P, Vigneri S, Scarlata P, Savarino V.

Am J Gastroenterol. 2008 Feb;103(2):267-75. doi: 10.1111/j.1572-0241.2007.01659.x.

PMID:
18289194
14.

Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus.

Vieth M, Kulig M, Leodolter A, Nauclér E, Jaspersen D, Labenz J, Meyer-Sabellek W, Lind T, Willich S, Malfertheiner P, Stolte M.

Aliment Pharmacol Ther. 2006 Jan 15;23(2):313-9.

15.

Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.

Peng S, Xiong LS, Xiao YL, Wang AJ, Lin JK, Hu PJ, Chen MH.

Chin Med J (Engl). 2010 Aug 5;123(15):2012-7.

PMID:
20819534
16.

Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.

Johnson DA, Orr WC, Crawley JA, Traxler B, McCullough J, Brown KA, Roth T.

Am J Gastroenterol. 2005 Sep;100(9):1914-22.

PMID:
16128933
17.

Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.

Gold BD, Gunasekaran T, Tolia V, Wetzler G, Conter H, Traxler B, Illueca M.

J Pediatr Gastroenterol Nutr. 2007 Nov;45(5):520-9.

PMID:
18030228
18.

Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.

Frazzoni M, Manno M, De Micheli E, Savarino V.

Dig Liver Dis. 2006 Feb;38(2):85-90. Epub 2005 Nov 10.

PMID:
16289976
19.

[Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].

Zheng J, Du ZM, Chen MH, Lin JK, Hu PJ.

Zhonghua Yi Xue Za Zhi. 2008 May 27;88(20):1390-3. Chinese.

PMID:
18953876

Supplemental Content

Support Center